Central Pharmaceutical Joint Stock Company No3: Net profit after tax surged 26.8% to VND 153.6 billion in 2025, with strong revenue growth

About this update from Central Pharmaceutical Jsc No. 3

Net revenue grew 4.9% year-over-year to VND 438.0 billion in 2025, with net profit after tax up 26.8% to VND 153.6 billion. Cash flow from operations turned positive, and EPS rose to VND 7,142.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Central Pharmaceutical Jsc No. 3